Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis
Overview
Authors
Affiliations
Osteoporosis is a common bone imbalance disease that threatens the health of postmenopausal women. Estrogen deficiency accelerates the aging of women. Oxidative stress damage is regarded as the main pathogenesis of postmenopausal osteoporosis. The accumulation of reactive oxygen species in the bone microenvironment plays a role in osteoblast and osteoclast apoptosis. Improving the oxidative state is essential for the prevention and treatment of postmenopausal osteoporosis. There are three classes of antioxidant defense systems in the body to eliminate free radicals and peroxides including antioxidant substances, antioxidant enzymes, and repair enzymes. In our review, we demonstrated the mechanism of antioxidants and their effect on bone metabolism in detail. We concluded that glutathione/oxidized glutathione (GSH/GSSG) conversion involved the PI3K/Akt-Nrf2/HO-1 signaling pathway and that the antioxidant enzyme-mediated mitochondrial apoptosis pathway of osteoblasts was necessary for the development of postmenopausal osteoporosis. Since the current therapeutic effects of targeting bone cells are not significant, improving the systemic peroxidation state and then regulating bone homeostasis will be a new method for the treatment of postmenopausal osteoporosis.
Modulatory effects of polysaccharide on bone cell dynamics in osteoporosis.
Wang Q, Zhang T, Feng X, Chen P, Feng Y, Huang H Open Med (Wars). 2025; 20(1):20241104.
PMID: 39989614 PMC: 11843162. DOI: 10.1515/med-2024-1104.
Akter R, Son J, Ahn J, Morshed M, Lee G, Kim M Int J Mol Sci. 2024; 25(13).
PMID: 39000355 PMC: 11241464. DOI: 10.3390/ijms25137247.
Xia X, Fang Z, Qian Y, Zhou Y, Huang H, Xu F J Cell Mol Med. 2024; 28(13):e18508.
PMID: 38953556 PMC: 11217991. DOI: 10.1111/jcmm.18508.
Zhang B, Qu Z, Hui H, He B, Wang D, Zhang Y Mol Med. 2024; 30(1):27.
PMID: 38378457 PMC: 10880252. DOI: 10.1186/s10020-024-00799-7.
Estrogen dysregulation, intraocular pressure, and glaucoma risk.
Youngblood H, Schoenlein P, Pasquale L, Stamer W, Liu Y Exp Eye Res. 2023; 237:109725.
PMID: 37956940 PMC: 10842791. DOI: 10.1016/j.exer.2023.109725.